Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01858311 · ClinicalTrials.gov registry record
Nutrition Blood Outcomes Following Tocotrienol N2B
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 300
- Enrollment target
NCT01858311 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 300 participants.
The verdict
NCT01858311 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
A natural form of vitamin E called tocotrienol (TCT) has blood thinning and cholesterol lowering properties, both of which may benefit stroke survivors. This study is being conducted to determine the blood thinning and cholesterol lowering properties of TCT in stroke or TIA (transient ischemic attack, which is also referred to as a "mini-stroke") survivors that are receiving the standard treatment for prevention of recurrent stroke. Study Hypothesis: Oral TCT decreases the incidence of aspirin and clopidogrel nonresponders, increases the extent of inhibition of platelet aggregation, and decreases LDL without significant side effects in stroke patients.
Interventions
- OTHER Placebo Vehicle
- DIETARY_SUPPLEMENT Tocotrienol Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01858311
The ClinicalTrials.gov registry entry for NCT01858311 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Vehicle is the first listed.
NCT01858311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01858311 about?
NCT01858311 is a clinical study titled "Nutrition Blood Outcomes Following Tocotrienol N2B". A natural form of vitamin E called tocotrienol (TCT) has blood thinning and cholesterol lowering properties, both of which may benefit stroke survivors. This study is being conducted to determine the blood thinning and cholesterol lowering properties of TCT in stroke or TIA (transient ischemic attac...
What is the current status of trial NCT01858311?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2013-03. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01858311?
The interventions under investigation include: Placebo Vehicle (OTHER), Tocotrienol Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01858311?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.